Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
CHINAHEALTHWISE (00348)
- 0.076
- -0.001-1.30%
Market Closed May 15 15:53 CST
58.56MMarket Cap-25.33P/E (TTM)
0.086High0.070Low714.00KVolume0.077Open0.077Prev Close53.52KTurnover0.09%Turnover RatioLossP/E (Static)770.48MShares0.22052wk High-2.81P/B58.56MFloat Cap0.05152wk Low--Dividend TTM770.48MShs Float13.533Historical High--Dividend LFY20.78%Range %0.034Historical Low0.075Avg Price10000Lot Size--Div Yield TTM--Div Yield LFY
CHINAHEALTHWISE (00348) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -12.34%99.56M | -16.20%51.06M | -22.38%113.58M | -24.61%60.93M | 3.00%146.32M | 5.97%80.83M | -16.48%142.06M | -22.09%76.27M | 23.38%170.08M | 33.74%97.9M |
| Operating income | -12.34%99.56M | -16.20%51.06M | -22.38%113.58M | -24.61%60.93M | 3.00%146.32M | 5.97%80.83M | -16.48%142.06M | -22.09%76.27M | 23.38%170.08M | 33.74%97.9M |
| Cost of sales | 13.28%-66.1M | 16.34%-34.53M | 11.39%-76.23M | 12.51%-41.27M | 3.11%-86.02M | 5.16%-47.17M | -12.27%-88.79M | -17.30%-49.74M | -2.98%-79.09M | -7.06%-42.4M |
| Operating expenses | 13.28%-66.1M | 16.34%-34.53M | 11.39%-76.23M | 12.51%-41.27M | 3.11%-86.02M | 5.16%-47.17M | -12.27%-88.79M | -17.30%-49.74M | -2.98%-79.09M | -7.06%-42.4M |
| Gross profit | -10.41%33.46M | -15.91%16.53M | -38.06%37.35M | -41.58%19.66M | 13.19%60.29M | 26.86%33.65M | -41.46%53.27M | -52.20%26.53M | 49.03%90.99M | 65.20%55.49M |
| Selling expenses | 2.77%-28.23M | 4.82%-14.07M | -4.17%-29.04M | -4.35%-14.78M | 2.34%-27.87M | 0.78%-14.16M | 8.17%-28.54M | 3.69%-14.28M | -3.51%-31.08M | 16.59%-14.82M |
| Administrative expenses | 18.11%-21.63M | 56.50%-7.86M | 29.62%-26.41M | -12.76%-18.07M | 2.09%-37.53M | 17.59%-16.02M | -15.84%-38.33M | -35.05%-19.44M | 4.48%-33.09M | 9.47%-14.4M |
| Revaluation surplus | ---100K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of derivative financial instruments | ---100K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 176.57%2.41M | 130.07%1.67M | 97.08%-3.15M | ---5.56M | -324.27%-107.79M | ---- | 76.00%-25.41M | ---- | -104.65%-105.85M | ---- |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -30.12%-216K | ---- |
| -Other impairment is provision | 176.57%2.41M | 130.07%1.67M | 97.08%-3.15M | ---5.56M | -324.27%-107.79M | ---- | 75.95%-25.41M | ---- | -104.89%-105.63M | ---- |
| Special items of operating profit | 334.98%24.63M | 321.32%12.02M | -3.09%-10.48M | 80.76%-5.43M | -0.70%-10.17M | -475.60%-28.24M | 33.34%-10.1M | -136.32%-4.91M | -1,308.78%-15.15M | 156.64%13.51M |
| Operating profit | 133.21%10.54M | 134.33%8.3M | 74.22%-31.73M | 2.41%-24.18M | -150.62%-123.07M | -104.79%-24.77M | 47.86%-49.1M | -130.41%-12.1M | -74.12%-94.17M | 266.23%39.78M |
| Financing cost | -66.62%-13.83M | -45.30%-6.77M | 7.72%-8.3M | -3.81%-4.66M | -23.24%-8.99M | -41.77%-4.49M | -13.84%-7.3M | 1.43%-3.17M | 65.99%-6.41M | 74.56%-3.21M |
| Earning before tax | 91.78%-3.29M | 105.31%1.53M | 69.69%-40.03M | 1.46%-28.83M | -134.14%-132.06M | -91.72%-29.26M | 43.92%-56.4M | -141.73%-15.26M | -37.91%-100.58M | 200.04%36.57M |
| Tax | 371.15%686K | -166.67%-114K | 89.88%-253K | 106.57%171K | -217.49%-2.5M | -3,125.58%-2.6M | 186.25%2.13M | --86K | -167.60%-2.47M | ---- |
| After-tax profit from continuing operations | 93.53%-2.61M | 104.95%1.42M | 70.06%-40.28M | 10.04%-28.66M | -147.92%-134.56M | -109.95%-31.86M | 47.33%-54.27M | -141.50%-15.18M | -48.74%-103.05M | 204.71%36.57M |
| Earning after tax | 93.53%-2.61M | 104.95%1.42M | 70.06%-40.28M | 10.04%-28.66M | -147.92%-134.56M | -109.95%-31.86M | 47.33%-54.27M | -141.50%-15.18M | -308.56%-103.05M | 194.70%36.57M |
| Profit attributable to shareholders | 93.53%-2.61M | 104.95%1.42M | 70.06%-40.28M | 10.04%-28.66M | -147.92%-134.56M | -109.95%-31.86M | 47.33%-54.27M | -141.50%-15.18M | -308.56%-103.05M | 194.70%36.57M |
| Basic earnings per share | 93.50%-0.0034 | 104.84%0.0018 | 70.05%-0.0523 | 10.14%-0.0372 | -148.01%-0.1746 | -110.15%-0.0414 | 47.34%-0.0704 | -141.47%-0.0197 | -311.38%-0.1337 | 196.15%0.0475 |
| Diluted earnings per share | 93.50%-0.0034 | 104.84%0.0018 | 70.05%-0.0523 | 10.14%-0.0372 | -148.01%-0.1746 | -110.15%-0.0414 | 47.34%-0.0704 | -143.49%-0.0197 | -311.38%-0.1337 | 191.70%0.0453 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"